Skip to search boxSkip to navigationSkip to main content

The transcription factor TEAD1 represses smooth Musclespecific gene expression by Abolishing Myocardin function

  • Fang Liu
    ,
  • Xiaobo Wang
    ,
  • Guoqing Hu
    ,
  • Yong Wang
    ,
  • Jiliang Zhou(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Background: The function of TEAD1 in the expression of smooth muscle-specific genes is unknown. Results: TEAD1 is induced after arterial injury and suppresses the expression of smooth muscle-specific genes by abolishing myocardin function. Conclusion: TEAD1 is a novel repressor for smooth muscle contractile gene expression. Significance: This study provides novel evidence that TEAD1 is critical for promoting phenotypic switching in smooth muscle cells. The TEAD (transcriptional enhancer activator domain) proteins share an evolutionarily conserved DNA-binding TEA domain, which binds to the MCAT cis-Acting regulatory element. Previous studies have shown that TEAD proteins are involved in regulating the expression of smooth muscleα-Actin. However, it remains undetermined whether TEAD proteins play a broader role in regulating expression of other genes in vascular smooth muscle cells. In this study, we show that the expression of TEAD1 is significantly induced during smooth muscle cell phenotypic modulation and negatively correlates with smooth muscle-specific gene expression. We further demonstrate that TEAD1 plays a novel role in suppressing expression of smooth muscle-specific genes, including smooth muscle α-Actin, by abolishing the promyogenic function of myocardin, a key mediator of smooth muscle differentiation. Mechanistically, we found that TEAD1 competes with myocardin for binding to serum response factor (SRF), resulting in disruption of myocardin and SRF interactions and thereby attenuating expression of smooth muscle-specific genes. This study provides the first evidence demonstrating that TEAD1 is a novel general repressor of smooth muscle-specific gene expression through interfering with myocardin binding to SRF.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 3308-3316 (9 pages)

Journal (Volume, Issue Number)

Journal of Biological Chemistry (Volume 289, Issue 6)

Publication milestones

  • Published - 02/07/2014

Publication status

Published - 02/07/2014

ISSN

0021-9258

Publication IDs

  • Scopus: 84893682691
  • PubMed: 24344135

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
SciVal
citations
27
SciVal
FWCI
1.16
SciVal
Author count
5
SciVal
Paper percentile
86

PlumX, opens in new tab

Citation count
46
Captures
44

Funding Details

FundersFunding number
National Institutes of Health, National Cancer Institute
-
NHLBI
R01HL109605